Danske Bank’s AEON Biopharma AEON Stock Holding History

Danske Bank’s Portfolio AEON Stock Details AEON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1	Hold	1	–	–	﹤0.01%	1155
2025 Q4	$1	Hold	1	–	–	﹤0.01%	1544
2025 Q3	$1	Hold	1	–	–	﹤0.01%	1476
2025 Q2	$1	Hold	1	–	–	﹤0.01%	1506
2025 Q1	$1	Buy	+1	New	+$7	﹤0.01%	1352

Other funds holding AEON

DIG

Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

FAM

Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Danske Bank's AEON Position: Q1 2026 in Review

Danske Bank held its AEON Biopharma (AEON) position steady in Q1 2026 at 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #1155.

Danske Bank first reported a position in AEON in Q1 2025 and has held it in 5 quarters since. 24 funds tracked by Wall St. Rank hold AEON as of Q1 2026.

Danske Bank held 1 share of AEON Biopharma worth $1 as of Q1 2026.
Danske Bank left its AEON Biopharma share count unchanged in Q1 2026.
AEON Biopharma made up ﹤0.01% of Danske Bank's portfolio in Q1 2026, its #1155 holding.
Danske Bank first reported a position in AEON Biopharma in Q1 2025 and has held it in 5 quarters since.
24 funds tracked by Wall St. Rank held AEON Biopharma as of Q1 2026.

Based on Danske Bank's 13F filing for Q1 2026, filed 12 May 2026.